1. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750–9.
2. Rao SS, Mudipalli RS, Stessman M, Zimmerman B. Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil 2004;16:580–96.
3. Rao SS, Tantiphlachiva K, Rao PS, et al. How useful is digital rectal examination in the assessment of patients with dyssynergia? Am J Gastroenterol 2007;S268:419.
4. Pepin C, Ladabuam U. The yield of lower endoscopy in patients with constipation: survey of a university hospital, public county hospital, and a Veterans Administration medical center. Gastrointest Endosc 2002;56:325–32.
5. Rao SS. Constipation: evaluation and treatment. Gastroenterol Clin North Am 2003;32:659–83.
6. Rao SS, Camilleri M, Hasler WL, et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil; 2011; 23: 8-23.
7. Savoye-Collet C, Savoye G, Koning E, et al. Defecography in symptomatic older women living at home. Age Ageing 2003;32:347–50.
8. Bolog N, Weishaupt D. Dynamic MR imaging of outlet obstruction. Rom J Gastroenterol 2005;14:293–302.
9. Rao SS, Kavlock R, Rao S. Influence of body position and stool characteristics on defecation in humans. Am J Gastroenterol 2006;101:2790–6.
10. Karlbom U, Lundin E, Graf W, Pahlman L. Anorectal physiology in relation to clinical subgroups of patients with severe constipation. Colorectal Dis 2004;6:343–9.
11. Chiarioni G, Whitehead WE, Pezza V, et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology 2006;130:657–64.
12. Rao SS, Seaton K, Miller M, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol 2007;5:331–8.
13. Chiarioni G, Saladini L, Whitehead W. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology 2005;129:86–97.
14. Heymen S, Scarlett Y, Jones K, et al. Randomized controlled trial shows biofeedback to be superior to alternate treatments for patients with pelvic floor dyssynergia-type defecation [abstract]. Am J Gastroenterol 2005;100:S335.
15. Hallan RI, Williams NS, Melling J, et al. Treatment of anismus in intractable constipation with botulinum A toxin. Lancet 1988;2:714–7.
16. Boccasanta P, Venturi M, Stuto A, et al. Stapled transanal rectal resection for outlet obstruction: a prospective, multicenter trial. Dis Colon Rectum 2004;47:1285–97.
17. Sharara AI, Azar C, Amr SS, et al. Solitary rectal ulcer syndrome: endoscopic spectrum and review of the literature. Gastrointest Endosc 2005;62:755–62.
18. Tjandra JJ, Fazio VW, Church JM, et al. Clinical conundrum of solitary rectal ulcer. Dis Colon Rectum 1992;35:227–34.
19. Felt-Bersma RJ, Cuesta A. Rectal prolapse, rectal intussusception, rectocele, and solitary rectal ulcer syndrome. Gastroenterol Clin North Am 2001;30:199–222.
20. Vaizey CJ, van den Bogaerde JB, Emmanuel AV, et al. Solitary rectal ulcer syndrome. Br J Surg 1998;85:1617–23.
21. Rao SS, Ozturk R, De Ocampo S, Stessman M. Pathophysiology and role of biofeedback therapy in solitary rectal ulcer syndrome. Am J Gastroenterol 2006;101:613–8.
22. Kumar M, Puri AS, Srivastava R, Yachha SK. Solitary rectal ulcer syndrome in a child treated with local sulfasalazine. Indian Pediatr 1994;31:1553–5.
23. Zargar SA, Khuroo MS, Mahajan R. Sucralfate retention enemas in solitary rectal ulcer. Dis Colon Rectum 1991;34:455–7.
24. Bishop PR, Nowicki MJ. Nonsurgical therapy for solitary rectal ulcer syndrome. Curr Treat Options Gastroenterol 2002;5:215–23.
25. Ederle A, Bulighin G, Orlandin PG, Pilati S. Endoscopic application of human fibrin sealant in the treatment of solitary rectal ulcer syndrome [letter]. Endoscopy 1992;24:736–7.
26. Jarrett ME, Emmanuel AV, Vaizey CJ, Kamm MA. Behavioural therapy (biofeedback) for solitary rectal ulcer syndrome improves symptoms and mucosal blood flow. Gut 2004;53:368–70.
27. Tweedie DJ, Varma JS. Long-term outcome of laparoscopic mesh rectopexy for solitary rectal ulcer syndrome. Colorectal Dis 2005;7:151–5.
28. Rao SS. Diagnosis and management of fecal incontinence. American College of Gastroenterology Practice Parameters Committee. Am J Gastrenterol 2004;99:1585–604.
29. Rao SS, Patel RS. How useful are manometric tests of anorectal function in the management of defecation disorders? Am J Gastroenterol 1997;92:469–75.
30. Rao SS. Pathophysiology of adult fecal incontinence. Gastroenterology 2004;126(1 Suppl 1):S14–22.
31. Deutekom M, Dobben AC, Terra MP, et al. Clinical presentation of fecal incontinence and anorectal function: what is the relationship? Am J Gastroenterol 2007;102:351–61.
32. Wald A. Con: anorectal manometry and imaging are not necessary in patients with fecal incontinence. Am J Gastroenterol 2006;101:2681–3.
33. Bharucha AE. Pro: anorectal testing is useful in fecal incontinence. Am J Gastroenterol 2006;101:2679–81.
34. Tuteja AK, Rao SS. Review article: recent trends in diagnosis and treatment of faecal incontinence. Aliment Pharmacol Ther 2004;19:829–40.
35. Terra MP, Beets-Tan RG, van der Hulst VP, et al. MRI in evaluating atrophy of the external anal sphincter in patients with fecal incontinence. AJR Am J Roentgenol 2006;187:991–9.
36. Sun WM, Read NW, Verlinden M. Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scan J Gastroenterol 1997;32:34–8.
37. Harford WV, Krejs GJ, Santa Ana CA, Fordtran JS. Acute effect of diphenoxylate with atropine (Lomotil) in patients with chronic diarrhea and fecal incontinence. Gastroenterol 1980;78:440–3.
38. Remes-Troche JM, Ozturk R, Philips C, et al. Cholesteryramine—a useful adjunct for the treatment of patients with fecal incontinence. Int J Colorectal Dis 2008;23:189–99.
39. Rao SS. The technical aspects of biofeedback therapy for defecation disorders. Gastroenterologist 1998;6:96–103.
40. Rao SS, Welcher KD, Happel J. Can biofeedback therapy improve anorectal function in fecal incontinence? Am J Gastroenterol 1966;91:2360–6.
41. Byrne CM, Solomon MJ, Young JM, et al. Biofeedback for fecal incontinence: short-term outcomes of 513 consecutive patients and predictors of successful treatment. Dis Colon Rectum 2007;50:417–27.
42. Norton C, Chelvanayagam S, Wilson-Barnett J, et al. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenteroloy 2003;125:1320–9.
43. Heymen S, Whitehead W. EMG biofeedback vs. Kegel exercise for the treatment of fecal incontinence. Gastroenterology 2007;132:A–83.
44. Pager CK, Solomon MJ, Rex J, Roberts RA. Long-term outcomes of pelvic floor exercise and biofeedback treatment for patients with fecal incontinence. Dis Colon Rectum 2002;45:997–1003.
45. Ozturk R, Niazi S, Stessman M, Rao SS. Long-term and objective changes of anorectal function after biofeedback therapy for faecal incontinence. Aliment Pharmacol Ther 2004;20:667–74.
46. Byrne CM, Solomon MJ, Rex J, et al. Telephone vs. face-to-face biofeedback for fecal incontinence: comparison of two techniques in 239 patients. Dis Colon Rectum 2005;48:2281–8.
47. Zorcolo L, Covotta L, Bartolo DC. Outcome of anterior sphincter repair for obstetric injury: comparison of early and late results. Dis Colon Rectum 2005;48:524–31.
48. Madoff RD. Surgical treatment options for fecal incontinence. Gastroenterology 2004;126(1 Suppl 1)S48–54.
49. Thornton MJ, Kennedy ML, Lubowski DZ, King DW. Long-term follow-up of dynamic graciloplasty for faecal incontinence. Colorectal Dis 2004;6:470–6.
50. Leroi AM, Parc Y, Lehur PA, et al. Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg 2005;242:662–9.
51. Vaizey CJ, Kamm MA, Nicholls RJ. Double-blind crossover study of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum 2000;43:298–302.
52. Graf W, Mellgren A, Matzel KE, et al. . Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet;2011;377:997–1003.
